SCHEMBL8223557

SCHEMBL8223557

CCCc1nn(C)nc1-c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 14/20 0.49
▸ MAPT P10636 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ USP2 O75604 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ HIF1A Q16665 2/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ GMNN O75496 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ ALOX12 P18054 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8212225 0.83 MAPT (0.42) MAPTLMNATP53KMT2ANPSR1
SCHEMBL8221326 0.81 KMT2A (0.44) MAPTKDM4EUSP2LMNATP53
SCHEMBL8220878 0.72 ALOX15 (0.50) ESR1MAPTKDM4EUSP2LMNA
SCHEMBL3270763 0.72 BRAF (0.50) MAPTKDM4EUSP2LMNACYP3A4
SCHEMBL28718113 0.67 ESR1 (0.42) ESR1MAPTKDM4EUSP2LMNA
Propylpyrazoletriol SCHEMBL426190 0.66 ESR1 (1.00) ESR1MAPTKDM4EUSP2LMNA
SCHEMBL21889053 0.66 SIGMAR1 (0.43) ESR1MAPTKDM4EUSP2LMNA
SCHEMBL23402943 0.65 MAPT (0.40) ESR1MAPTKDM4EUSP2LMNA
SCHEMBL21051412 0.65 ESR1 (0.52) ESR1MAPTKDM4EUSP2LMNA
SCHEMBL8214582 0.65 KMT2A (0.40) ESR1MAPTKDM4EUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021871-A2 TRIAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed
Send feedback